P

Provigil

Drug manufacturers agreed to pay over $65 million to resolve claims of price-fixing involving Provigil, Nuvigil, and generic modafinil.

ClosedUnited States-wideClaim status: Claim window closedPayout: Up to $2,500No longer claimable

About this settlement

The settlement addresses claims of illegal price-fixing that increased the cost of Provigil and related drugs.

This settlement resolves allegations that several drug manufacturers engaged in a price-fixing scheme involving Provigil, Nuvigil, and generic modafinil, resulting in a payout fund exceeding $65 million.

Who qualifies

  • Individuals who purchased Provigil, Nuvigil, or generic modafinil during the relevant period.
  • Claimants from any U.S. state.

Up to $2,500

Claim status: Claim window closed

See active Settlements